Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prevalence and Outcomes of Amyloid Positivity Among Persons Without Dementia in a Longitudinal, Population-Based Setting

Published:2018-08-01 Issue:8 Volume:75 Page:970
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Roberts Rosebud O.¹²,Aakre Jeremiah A.¹,Kremers Walter K.¹,Vassilaki Maria¹,Knopman David S.²,Mielke Michelle M.¹²,Alhurani Rabe²,Geda Yonas E.¹³,Machulda Mary M.⁴,Coloma Preciosa⁵,Schauble Barbara⁶,Lowe Val J.⁷,Jack Clifford R.⁷,Petersen Ronald C.¹²

Affiliation:

1. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota

2. Department of Neurology, Mayo Clinic, Rochester, Minnesota

3. Department of Psychiatry and Psychology and Neurology, Mayo Clinic, Scottsdale, Arizona

4. Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota

5. Real World Data Science, F. Hoffmann-La Roche Ltd, Basel, Switzerland

6. Medical Affairs, F. Hoffmann-La Roche Ltd, Basel, Switzerland

7. Department of Radiology, Mayo Clinic, Rochester, Minnesota

Publisher

American Medical Association (AMA)

Subject

Clinical Neurology

Reference34 articles.

1. Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria.;Dubois;Lancet Neurol,2007

2. Preclinical Alzheimer’s disease: Definition, natural history, and diagnostic criteria.;Dubois;Alzheimers Dement,2016

3. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.;Sperling;Alzheimers Dement,2011

4. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease.;Albert;Alzheimers Dement,2011

5. Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease.;Knopman;Neurology,2012

Cited by 136 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tau PET positivity predicts clinically relevant cognitive decline driven by Alzheimer’s disease compared to comorbid cases; proof of concept in the ADNI study;Molecular Psychiatry;2024-08-23

2. Space-Like Irradiation Exacerbated Cognitive Deficits and Amyloid Pathology in CRND8 Mouse Model of Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-08-20

3. Blood Astrocyte Biomarkers in Alzheimer Disease;Neurology;2024-08-13

4. Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics;Frontiers in Aging Neuroscience;2024-08-09

5. Considering challenges for the new Alzheimer's drugs: Clinical, population, and health system perspectives;Alzheimer's & Dementia;2024-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3